Hutch News
Results per Page:
Abnormal bone marrow findings post CAR-T cell therapy help uncover responses to treatment
From the Yeung and Naresh labs, Translational Sciences and Therapeutics Division
Macrophages predict response to immunotherapy in Merkel cell carcinoma
From the Nghiem lab, Fred Hutch Clinical Research Division & UW Dermatology
Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center
International expert will help scale up Fred Hutch’s clinical expertise in solid tumor immunotherapy
Cancer care: From ‘sledgehammer’ to precision cellular therapy
AACR progress report: new immunotherapies improve outcomes, but access to care and clinical trials for many still lags
A new study urges CARe when considering multispecific CAR-T cell therapy
From the Riddell Lab, Translational Science and Therapeutics Division
Dr. Philip Greenberg elected to National Academy of Sciences
Fred Hutch expert in immunology has led development of T-cell therapies for cancer
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
Immune signature reveals new therapeutic potential in colon cancer
From Dr. Jeroen Huyghe and the Peters Lab, Public Health Sciences Division
Award will fund research into new metastatic prostate cancer therapies
Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Fred Hutchinson Cancer Center receives $710.5 million gift to accelerate cancer and infectious disease research
The landmark gift from the Bezos family will fund multiple scientific priorities, including clinical trials support, new translational research capabilities and recruitment
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
Making immunotherapy more effective against small cell lung cancer
Human trial opens after experimental drug improves tumor growth suppression in mice
Hutch scientists receive $25M to solve breast cancer metastasis
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread